- Product Detail
- Product Tags
- Buyer Reviews
In the past few years, our organization absorbed and digested state-of-the-art technologies equally at home and abroad. Meanwhile, our enterprise staffs a team of experts devoted towards the growth of Btk Inhibitor 1 R EnantioMer Intermeidate,Ibrutinib N-1 Ingredient 99%,Targeted Covalent Drug Powder. please contact us freely.
Chemical Name: 3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine
Molecular Formula: C22H22N6O
Formula Weight: 386.44968
CAS No.: 1022150-12-4
Ibrutinib is an orally bioavailable, small-molecule inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon oral administration, ibrutinib binds to and irreversibly inhibits BTK activity, thereby preventing both B-cell activation and B-cell-mediated signaling. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is required for B cell receptor signaling, plays a key role in B-cell maturation, and is overexpressed in a number of B-cell malignancies. The expression of BTK in tumor cells is also associated with increased proliferation and survival.
"Innovation, excellent and reliability are the core values of our company. These principles today much more than ever form the basis of our success as an internationally active mid-size business for Ibrutinib Intermediate Cas 1022150-12-4. The product will supply to all over the world, such as: Gabon,Switzerland,Trinidad and Tobago. In order to make more people know our products and solutions and to enlarge our market we've devoted a lot of attention to technical innovations and improvement as well as replacement of equipment. Last but not the least we also pay more attention to training our managerial personnel technicians and workers in planned way.
Email To This Supplier